Veracyte Announces Fourth Quarter and Full-Year 2015 Financial Results, Provides 2016 Financial Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall St tumbles on tech selloff as concerns about hawkish Fed, AI spending mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil drops $1 as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Leerink Partners Remains Bullish as Low Operating Expenses Drives Veracyte's (VCYT) EPS Beat
March 11, 2016 10:02 AM ESTLeerink Partners maintained an Outperform rating on Veracyte, Inc (NASDAQ: VCYT), and cut the price target to $8.00 (from $11.00), following the company's 4Q earnings report. VCYT reported Q4 revenue of $14M, below consensus of $14.3M. Also, Q4 loss per shares of ($0.29) was better than consensus... More
Veracyte (VCYT) Tops Q4 EPS by 1c
March 10, 2016 4:36 PM ESTVeracyte (NASDAQ: VCYT) reported Q4 EPS of ($0.29), $0.01 better than the analyst estimate of ($0.30). Revenue for the quarter came in at $14 million versus the consensus estimate of $14.45 million.
GUIDANCE:
Veracyte sees FY2016 revenue of $59-63 million, versus the consensus of $62.9... More
